Transplant Diagnostics Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Brazil, Mexico, Saudi Arabia, South Africa), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Report ID: GMI2816

  Table of Contents Inquiry Before Buying
Summary Methodology Request for Customization

Transplant Diagnostics Market size is projected to experience significant growth from 2018 to 2024.
 

Growing disease burden across globe is key factor that will drive global transplant diagnostics market growth during the forecast period. According to Global Observatory on Donation and Transplantation, around 1,26,670 solid organ transplants were done in 2015 globally. That included 84,347 kidney transplants, 27,759 liver transplants, 7023 heart transplants and 5046 lung transplants. Rising incidence of cardiac failure, kidney failure and other chronic diseases will upsurge transplant diagnostics market size in the forthcoming years.
 

Technological advancements in transplant diagnostic techniques will serve to be another impact rendering factor. Increasing adoption of effective and early diagnostic techniques during transplantation procedures will fuel the need for improved diagnostic techniques. However, stringent government regulations for organ transplant such as Organ Transplantation Act may impede the global transplant diagnostics market growth over the forecast period. Furthermore, availability of advanced alternatives for liver and heart transplants may restrain the market growth to some extent.

 

Reagents and consumables segment is expected to show robust growth during the forthcoming years. Growing prevalence of diseases leading to organ failure should boost business growth. Growing patient demand for effective patient profiling during transplantation procedures will serve to be positive impact rendering factor. Increasing acceptance of transplant diagnostic techniques in various research studies will further upsurge segmental growth.
 

Solid organ transplant segment is estimated to account for highest revenue share owing to increasing prevalence of chronic diseases leading to organ failure. Various government initiatives to increase organ donation will drive the segmental growth. Advancements in transplant diagnostic techniques, growing patient demand for organ transplantation will offer immense scope for market growth over the coming years.
 

Micro-assay segment will show highest CAGR during the forecast timeframe due to its vivid applications in patient profiling. Adoption of advanced molecular assays by physicians is increasing in recent years due to its benefits such as efficacy, accuracy and low risk. For instance, HLA typing is more precise and competent as compared to serological assays. Aforementioned factors will propel micro-assay segment growth in the forthcoming years.
 

Diagnostic applications segment dominated transplant diagnostics market in 2017 as a result of increasing prevalence of various cardiovascular, gastrointestinal, respiratory and other chronic diseases. Increasing awareness among people pertaining to organ transplantation and stem cell therapies is estimated to drive segmental growth. Risks and intricacies associated with organ transplant will spur demand for advanced diagnostic tools.
 

Hospitals and transplant centers segment held largest market share in 2017 and is projected to show significant growth throughout the forecast period. Availability of advanced equipment and skilled healthcare professionals in hospitals and transplant centers will upsurge segment revenue size. Moreover, growing prevalence of chronic diseases leading to increasing number of transplant procedures will augment segmental growth in the coming years.
 

U.S. transplant diagnostics market accounted for highest revenue share in 2017. The growth is attributing to high adoption of advanced diagnostic tools, presence of highly advanced healthcare infrastructure as well as availability of skilled healthcare professionals. Furthermore, high demand for personalized medicines and awareness among people regarding stem cell therapies will foster regional growth.
 

Indian transplant diagnostics market is estimated to witness robust growth over the forecast period. Presence of large patient pool in the nation is the key factor that will drive market growth. Moreover, rising disposable income coupled with increasing demand for advanced technologies and developments in healthcare facilities will boost Indian transplant diagnostics market growth.
 

Some of the notable industry players in transplant diagnostics market include Becton, Dickinson & Company, Biofortuna, Biomrieux, Bio-Rad Laboratories, CareDx, F. Hoffman-La Roche, GenDx, Hologic, Illumina, Immucor, Luminex, Merck, Omixon, Qiagen and Thermo Fisher. Industry players primarily focus on strategic collaboration, merger, acquisitions and innovative product launch as their key strategies to expand existing product portfolio and capture high revenue share.
 

Transplant diagnostics market by product type, 2013-2024 (USD Million)

  • Reagents & consumables
  • Instruments & equipment
  • Software & services

Transplant diagnostics market by transplant type, 2013-2024 (USD Million)

  • Solid organ transplant
  • Soft tissue transplant
  • Stem cell transplant

Transplant diagnostics market by technology, 2013-2024 (USD Million)

  • Molecular assay
  • Non-molecular assay

Transplant diagnostics market by application, 2013-2024 (USD Million)

  • Diagnostic applications
    • Pre-transplantation diagnostics
    • Post-transplantation diagnostics
  • Research applications

Transplant diagnostics market by end-use, 2013-2024 (USD Million)

  • Hospitals & transplant centers
  • Research laboratories
  • Academic institutes

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • Saudi Arabia
    • South Africa

Company Profiles:

  • Becton, Dickinson & Company
  • Biofortuna
  • Biomrieux
  • Bio-Rad Laboratories
  • CareDx
  • F. Hoffman-La Roche
  • GenDx
  • Hologic
  • Illumina
  • Immucor
  • Luminex
  • Merck
  • Omixon
  • Qiagen
  • Thermo Fisher

What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Request for Customization

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree